A Randomized, Single-Blind, Group Sequential, Active-Controlled Study to Evaluate the Clinical Efficacy and Safety of α-Lipoic Acid for Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)

What a curious place to have this study 🤔 Wuhan. China. https://t.co/0qMRg4drK0

@vvalkyri @calirunnerdoc @YouAreLobbyLud Here’s one on the benefits of alpha lipoic acid. https://t.co/2CKhR9fNRq

This is the smallest #RCT I've ever seen: Critically Ill #COVID19 were randomized to α-Lipoic Acid (n=8) versus placebo (n=9) If a patient wouldn't have died at day 29 in the α-Lipoic Acid there would have been a significant mortality reduction😷😷 https://t

A Randomized, Single-Blind, Group Sequential, Active-Controlled Study to Evaluate the Clinical Efficacy and Safety of α-Lipoic Acid for Critically Ill Patients With Coronavirus Disease 2019 (COVID-19) | Medicine https://t.co/n17QyXQIfa